[1
]
From Memorial Sloan Kettering Cancer Center, New York (D.M.H., E.L.D., J.B.); Vanderbilt
University Medical Center, Nashville (I.P., E.C.); University of Texas M.D. Anderson
Cancer Center, Houston (V.S.); Massachusetts General Hospital, Boston (J.E.F., N.S.R.);
Royal Marsden Hospital, Sutton, Surrey, United Kingdom (I.C.); Centre Léon Bérard,
Lyon (J.-Y.B.), Institut Gustave Roussy, Villejuif (A.H.), Centre François Baclesse,
Centre Hospitalier Universitaire Côte de Nacre, Caen (R.G.), and Institut Bergonié
Cancer Center, Bordeaux (A.I.) - all in France; University Hospital of Cologne, Cologne
(J.W.), Universitätsmedizin Mannheim, Mannheim (R.-D.H.), West German Cancer Center,
University Hospital Essen, Essen (M.S.), and German Cancer Consortium, Heidelberg
(M.S.) - all in Germany; Vall d'Hebron University Hospital and Institute of Oncology,
Universitat Autònoma de Barcelona, Barcelona (M.E.E.-F., J.T.), and Hospital Universitario
Madrid Sanchinarro, Madrid (M.H.) - both in Spain; and F. Hoffmann-La Roche, Basel,
Switzerland (S.F.L., M.M., F.S., M.L.V.).